Today: 12 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

GE Vernova stock (GEV) rises even as a Japan wind delay puts turbines back in focus

GE Vernova stock (GEV) rises even as a Japan wind delay puts turbines back in focus

GE Vernova shares rose 1.9% to $694.32 Tuesday, bucking a broader market drop. Mitsui & Co’s offshore wind project in Japan will switch to smaller turbines and delay construction by a year after GE Vernova scrapped its 18-MW model. The SPDR S&P 500 ETF fell about 1.1%. Offshore wind developers continue to adjust plans as costs rise.
20 January 2026
·····
AST SpaceMobile stock barely budges after Deutsche Bank lifts target to $137

AST SpaceMobile stock barely budges after Deutsche Bank lifts target to $137

AST SpaceMobile shares slipped 0.2% to $115.59 Tuesday after Deutsche Bank raised its price target to $137. The company is producing six satellites a month in Midland, Texas, and expects to launch its seventh satellite, BlueBird FM2, in the coming weeks. AST aims for 45 to 60 satellites in orbit by year-end. Investors are watching for launch execution, hardware performance, and regulatory updates.
20 January 2026
···
Applied Materials stock slides nearly 3% as tariff fears whip markets, despite fresh Needham boost

Applied Materials stock slides nearly 3% as tariff fears whip markets, despite fresh Needham boost

Applied Materials shares fell 2.8% to $317.70 Tuesday, underperforming the tech sector as Trump’s renewed tariff threats on Europe drove volatility higher. The Cboe Volatility Index hit an eight-week high. Investors shifted focus to Applied’s Feb. 12 earnings report. A Needham analyst raised the company’s price target to $390, citing strong chip-tool demand.
20 January 2026
·
Eli Lilly stock price edges higher after FDA breakthrough nod for ovarian cancer drug

Eli Lilly stock price edges higher after FDA breakthrough nod for ovarian cancer drug

Eli Lilly shares rose about 0.2% Tuesday after the FDA granted Breakthrough Therapy designation to its experimental ovarian cancer drug, sofetabart mipitecan. The stock traded near $1,040 as the broader market fell 1%. The designation covers patients with platinum-resistant disease who have tried other therapies. Bernstein maintained its Outperform rating and $1,300 price target.
20 January 2026
··
JPMorgan stock price slips as Trump’s 10% credit card cap deadline puts bank shares under pressure

JPMorgan stock price slips as Trump’s 10% credit card cap deadline puts bank shares under pressure

JPMorgan Chase shares fell 0.9% to $309.64 in morning trading as investors reacted to uncertainty over a proposed 10% cap on U.S. credit card interest rates. The American Bankers Association warned the cap could force 137–159 million cardholders to lose access or face sharply reduced credit lines. Citigroup and Morgan Stanley shares also declined. The White House faces a January 20 deadline, but enforcement remains unclear.
20 January 2026
·
Natural gas price spikes on Arctic forecast shift; UNG jumps as EQT, Range rally

Natural gas price spikes on Arctic forecast shift; UNG jumps as EQT, Range rally

Front-month Henry Hub natural gas futures jumped about 20% to $3.74/mmBtu Tuesday as forecasts signaled colder weather for late January. The U.S. Natural Gas Fund rose over 15%, and shares of major gas producers gained in morning trading. Traders now await Thursday’s storage data and further weather model updates to confirm the cold outlook.
20 January 2026
······
Nvidia stock slides as Trump tariff threats hit AI stocks; Microsoft, Broadcom fall

Nvidia stock slides as Trump tariff threats hit AI stocks; Microsoft, Broadcom fall

Nvidia dropped 3.4% to $179.83, dragging AI stocks lower as U.S. markets fell on tariff threats from President Trump over Greenland. The Nasdaq lost 1.6% and S&P 500 slid 1.3% in early trading. Morgan Stanley downgraded IT hardware, citing weak demand and high costs. Microsoft, Broadcom, and Palantir also declined, while AMD rose 1.3%.
20 January 2026
············
Bitcoin price slides toward $90,000 as Trump’s Greenland tariff threat hits risk appetite

Bitcoin price slides toward $90,000 as Trump’s Greenland tariff threat hits risk appetite

Bitcoin dropped 3.1% to $90,028 in New York Tuesday as investors sold risk assets after President Trump threatened tariffs on Europe over Greenland. Crypto stocks fell, with Coinbase down 5.4% and Strategy Inc off 8.2%. Ether slid 6.5%. U.S. equity indexes hit three-week lows; European stocks and the dollar also weakened. Crypto markets saw $869.5 million in liquidations over 24 hours, CoinGlass reported.
20 January 2026
·····
Silver price hits a fresh record as Trump tariff threat jolts markets

Silver price hits a fresh record as Trump tariff threat jolts markets

Spot silver rose 0.7% to $95.308 an ounce Tuesday, briefly hitting a record $95.488, as investors sought safe havens after President Trump announced new tariffs on several European countries. The S&P 500 and Nasdaq fell over 1% early in the session, while gold surged past $4,700. The dollar weakened against the yen and Swiss franc. Traders are watching upcoming Supreme Court arguments involving the Federal Reserve.
20 January 2026
··
Dow Jones slides 600 points as Trump’s Greenland tariff threat rattles Wall Street

Dow Jones slides 600 points as Trump’s Greenland tariff threat rattles Wall Street

The Dow Jones fell over 600 points Tuesday after President Trump threatened new tariffs on European nations amid the Greenland dispute. 3M shares dropped on a weak 2026 profit forecast, while major banks slipped as the White House pushed for a 10% cap on credit-card rates. The 10-year Treasury yield rose to near 4.29%. Netflix will report earnings after the close.
20 January 2026
···
RAPT stock price jumps as GSK strikes $2.2 billion buyout for food allergy drug

RAPT stock price jumps as GSK strikes $2.2 billion buyout for food allergy drug

RAPT Therapeutics shares soared 64% to $57.54 after GSK announced a $58-per-share cash acquisition, valuing the biotech at $2.2 billion. The deal centers on ozureprubart, an experimental anti-IgE drug for food allergies. GSK plans to launch a tender offer within 10 business days, pending antitrust review. RAPT’s stock hovered just below the offer price as investors watched for regulatory developments.
20 January 2026
···
Intel stock jumps as HSBC, Seaport upgrades sharpen focus on Jan. 22 earnings

Intel stock jumps as HSBC, Seaport upgrades sharpen focus on Jan. 22 earnings

Intel shares rose 4.9% to $49.25 Tuesday after Seaport and HSBC raised price targets and ratings ahead of the company’s Jan. 22 earnings report. Seaport set a $65 target, citing PC market share gains and chip advances, while HSBC lifted its target to $50 on stronger server CPU demand from AI. Options trading signals expectations of an 8.8% move after results. The S&P 500 and Nasdaq 100 fell about 1.4%.
20 January 2026
···
Google stock drops with Big Tech as tariff jitters hit Wall Street; Alphabet earnings next test

Google stock drops with Big Tech as tariff jitters hit Wall Street; Alphabet earnings next test

Alphabet Inc’s Class C shares fell 2.1% to $323.47 early Tuesday after U.S. markets dropped on new tariff threats from President Trump targeting Europe. About 4.9 million shares changed hands as the stock traded between $317.10 and $325.17. Alphabet’s Frankfurt-listed shares slid 2.4% Monday while U.S. markets were closed. The company will report fourth-quarter and full-year earnings on Feb. 4.
20 January 2026
··
Palantir stock slips despite HD Hyundai deal worth “hundreds of millions” — what PLTR investors watch next

Palantir stock slips despite HD Hyundai deal worth “hundreds of millions” — what PLTR investors watch next

Palantir shares fell about 2% to $167.58 Tuesday morning despite announcing a multi-year software deal with South Korea’s HD Hyundai, reportedly worth hundreds of millions of dollars. The drop followed a broader tech sell-off. Investors are focused on Palantir’s Feb. 2 earnings for signs of commercial revenue growth. Neither company disclosed the exact value of the expanded contract.
20 January 2026
·
1 … 256 257 258 259 260 … 700

Stock Market Today

  • NVIDIA Stock Dips 1.5% Amid Insider Selling; Analysts Maintain Strong Buy Ratings
    March 12, 2026, 6:05 PM EDT. Shares of NVIDIA Corporation (NASDAQ:NVDA) fell 1.5% on Thursday following insider selling by EVP Ajay K. Puri, who offloaded 300,000 shares valued at over $54 million. The stock traded as low as $181.75 before closing near $183. Analysts remain bullish, with price targets ranging up to $300 and multiple "buy" and "strong buy" ratings. Notably, Sanford C. Bernstein and Cantor Fitzgerald raised their targets recently, highlighting confidence despite the insider sale. NVIDIA's ongoing strategic partnerships and AI product advancements bolster investor sentiment, underscoring demand for its GPUs and data-center solutions.
Go toTop